Marine Benthic Cyanobacteria Contain Apoptosis-Inducing Activity Synergizing with Daunorubicin to Kill Leukemia Cells, but not Cardiomyocytes

The potential of marine benthic cyanobacteria as a source of anticancer drug candidates was assessed in a screen for induction of cell death (apoptosis) in acute myeloid leukemia (AML) cells. Of the 41 marine cyanobacterial strains screened, more than half contained cell death-inducing activity. Sev...

Full description

Bibliographic Details
Main Authors: Stein Ove Døskeland, Lars Herfindal, Kaarina Sivonen, Matti Wahlsten, Frode Selheim, Linn Oftedal
Format: Article
Language:English
Published: MDPI AG 2010-10-01
Series:Marine Drugs
Subjects:
Online Access:http://www.mdpi.com/1660-3397/8/10/2659/
_version_ 1811185289568190464
author Stein Ove Døskeland
Lars Herfindal
Kaarina Sivonen
Matti Wahlsten
Frode Selheim
Linn Oftedal
author_facet Stein Ove Døskeland
Lars Herfindal
Kaarina Sivonen
Matti Wahlsten
Frode Selheim
Linn Oftedal
author_sort Stein Ove Døskeland
collection DOAJ
description The potential of marine benthic cyanobacteria as a source of anticancer drug candidates was assessed in a screen for induction of cell death (apoptosis) in acute myeloid leukemia (AML) cells. Of the 41 marine cyanobacterial strains screened, more than half contained cell death-inducing activity. Several strains contained activity against AML cells, but not against non-malignant cells like hepatocytes and cardiomyoblasts. The apoptotic cell death induced by the various strains could be distinguished by the role of caspase activation and sensitivity to the recently detected chemotherapy-resistance-associated prosurvival protein LEDGF/p75. One strain (M44) was particularly promising since its activity counteracted the protective effect of LEDGF/p75 overexpressed in AML cells, acted synergistically with the anthracycline anticancer drug daunorubicin in AML cells, and protected cardiomyoblasts against the toxic effect of anthracyclines. We conclude that culturable benthic marine cyanobacteria from temperate environments provide a promising and hitherto underexploited source for novel antileukemic drugs.
first_indexed 2024-04-11T13:27:01Z
format Article
id doaj.art-adb5f20861a24c8ab8e2b7e757784cb6
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-04-11T13:27:01Z
publishDate 2010-10-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-adb5f20861a24c8ab8e2b7e757784cb62022-12-22T04:22:01ZengMDPI AGMarine Drugs1660-33972010-10-018102659267210.3390/md8102659Marine Benthic Cyanobacteria Contain Apoptosis-Inducing Activity Synergizing with Daunorubicin to Kill Leukemia Cells, but not CardiomyocytesStein Ove DøskelandLars HerfindalKaarina SivonenMatti WahlstenFrode SelheimLinn OftedalThe potential of marine benthic cyanobacteria as a source of anticancer drug candidates was assessed in a screen for induction of cell death (apoptosis) in acute myeloid leukemia (AML) cells. Of the 41 marine cyanobacterial strains screened, more than half contained cell death-inducing activity. Several strains contained activity against AML cells, but not against non-malignant cells like hepatocytes and cardiomyoblasts. The apoptotic cell death induced by the various strains could be distinguished by the role of caspase activation and sensitivity to the recently detected chemotherapy-resistance-associated prosurvival protein LEDGF/p75. One strain (M44) was particularly promising since its activity counteracted the protective effect of LEDGF/p75 overexpressed in AML cells, acted synergistically with the anthracycline anticancer drug daunorubicin in AML cells, and protected cardiomyoblasts against the toxic effect of anthracyclines. We conclude that culturable benthic marine cyanobacteria from temperate environments provide a promising and hitherto underexploited source for novel antileukemic drugs.http://www.mdpi.com/1660-3397/8/10/2659/AMLcyanobacteriaapoptosiscancerleukemia
spellingShingle Stein Ove Døskeland
Lars Herfindal
Kaarina Sivonen
Matti Wahlsten
Frode Selheim
Linn Oftedal
Marine Benthic Cyanobacteria Contain Apoptosis-Inducing Activity Synergizing with Daunorubicin to Kill Leukemia Cells, but not Cardiomyocytes
Marine Drugs
AML
cyanobacteria
apoptosis
cancer
leukemia
title Marine Benthic Cyanobacteria Contain Apoptosis-Inducing Activity Synergizing with Daunorubicin to Kill Leukemia Cells, but not Cardiomyocytes
title_full Marine Benthic Cyanobacteria Contain Apoptosis-Inducing Activity Synergizing with Daunorubicin to Kill Leukemia Cells, but not Cardiomyocytes
title_fullStr Marine Benthic Cyanobacteria Contain Apoptosis-Inducing Activity Synergizing with Daunorubicin to Kill Leukemia Cells, but not Cardiomyocytes
title_full_unstemmed Marine Benthic Cyanobacteria Contain Apoptosis-Inducing Activity Synergizing with Daunorubicin to Kill Leukemia Cells, but not Cardiomyocytes
title_short Marine Benthic Cyanobacteria Contain Apoptosis-Inducing Activity Synergizing with Daunorubicin to Kill Leukemia Cells, but not Cardiomyocytes
title_sort marine benthic cyanobacteria contain apoptosis inducing activity synergizing with daunorubicin to kill leukemia cells but not cardiomyocytes
topic AML
cyanobacteria
apoptosis
cancer
leukemia
url http://www.mdpi.com/1660-3397/8/10/2659/
work_keys_str_mv AT steinovedøskeland marinebenthiccyanobacteriacontainapoptosisinducingactivitysynergizingwithdaunorubicintokillleukemiacellsbutnotcardiomyocytes
AT larsherfindal marinebenthiccyanobacteriacontainapoptosisinducingactivitysynergizingwithdaunorubicintokillleukemiacellsbutnotcardiomyocytes
AT kaarinasivonen marinebenthiccyanobacteriacontainapoptosisinducingactivitysynergizingwithdaunorubicintokillleukemiacellsbutnotcardiomyocytes
AT mattiwahlsten marinebenthiccyanobacteriacontainapoptosisinducingactivitysynergizingwithdaunorubicintokillleukemiacellsbutnotcardiomyocytes
AT frodeselheim marinebenthiccyanobacteriacontainapoptosisinducingactivitysynergizingwithdaunorubicintokillleukemiacellsbutnotcardiomyocytes
AT linnoftedal marinebenthiccyanobacteriacontainapoptosisinducingactivitysynergizingwithdaunorubicintokillleukemiacellsbutnotcardiomyocytes